In Deloitte’s “2016 U.S. Life Sciences Industry Outlook” released in January, Greg Reh, the firm’s U.S. and Global Life Sciences sector leader, offered a somewhat encouraging assessment of employment prospects this year: “Despite current economic, political, technological, and social challenges, life sciences companies worldwide should see enough long-term growth opportunities to feel cautiously optimistic about 2016.”
Three such opportunities were identified by recruiting firm Smith Hanley Associates earlier this year: One was candidate movement to smaller biopharmas, which the firm said leads to higher base salaries as companies scramble to offset the loss of long-term incentives given by big pharma. Mergers and acquisitions create jobs for candidates willing to relocate, whereas the growth of big data adds positions for in-house data scientists but also results in project outsourcing to vendors that creates new markets and innovations, Smith Hanley added.
All those trends should mean more work for biopharma recruiters, who match employers with job candidates in significant portions of the industry.
Originally published by Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News.
About The Bowdoin Group
Founded in 1994, The Bowdoin Group is an award-winning executive search firm that specializes in leadership and strategic roles for a wide range of companies, from small firms building out their executive team to large firms sourcing talent for rapid market expansion. With deep expertise in BioPharma, Digital Health, FinTech and Financial Services, and Software, The Bowdoin Group is a leader in the Greater Boston area with depth of experience in sourcing talent and servicing companies globally. The company’s service reputation earned it a ranking in the top 2% of the recruiting industry for client satisfaction. Bowdoin is active in supporting Boston’s entrepreneurial ecosystem as well as several non-profit causes.